AI in Healthcare

Today's Stories

1. 1

   Vitality AI enters US with 180% ROI claim

   Vitality and Google extended Vitality AI into the United States. The platform runs on Google Cloud and Gemini Enterprise, and internationally has delivered a 180% ROI and an estimated 6 deaths prevented. Employers gain a proven tool to address low engagement and rising benefit costs.

   The 180% ROI and health outcomes come from international markets, so U.S. results may vary. Watch how many U.S. employers adopt the platform and whether the same 4% claims reduction holds.

2. 2

   FDA, Sanofi, Gilead Weigh AI Readiness and Validation Risk

   At the PDA/FDA Conference, the FDA, Sanofi, and Gilead weighed AI readiness and validation risk. The discussion signals that life-sciences firms are treating AI validation as a live risk area, not just a technical detail.

   How the FDA and drugmakers resolve validation risk will shape what AI tools can clear regulatory hurdles.

3. 3

   Taiwan, China speakers: hospital AI must be local

   At a healthcare AI forum in Wonju on Thursday, September 17, speakers from Taiwan and China argued that AI for hospitals must be built for local patients, local languages, and local clinical guidelines. The speakers' position suggests generic hospital AI may not fit local clinical practice, so buyers may need tools tailored to their own patients and guidelines.

   Whether vendors from Taiwan and China will adapt products to local needs, and whether the Wonju forum leads to concrete deployments rather than continued trials.

4. 4

   Clinic runs on Mac Studio: Dr. 村岡洋典 builds in-house local LLM

   Honjo Masago Heart Clinic's director 村岡洋典 built a local LLM setup on Apple's Mac Studio, used mainly to summarize past records and assist voice-to-chart transcription. The clinic says all processing stays on in-house equipment and lets patients opt out of having their data fed to the AI, so sensitive exam content is not sent outside.

   Few clinics can build this themselves; vendor GENSHI AI says its local LLM business is new but has received more than 20 inquiries, with setup from about 4 million yen plus roughly 300,000 yen monthly maintenance.

5. 5

   Pharma doubles down on AI to slash costs, timelines

   The pharma sector is doubling down on AI to slash costs and timelines, per Reuters. This signals that drugmakers see AI as a way to reduce expenses and speed up development.

   Watch whether these AI bets actually shorten timelines and cut costs in practice.

6. 6

   Bristol Myers Squibb Leads Enterprise AI Procurement

   Procurement Magazine reports that Bristol Myers Squibb is leading enterprise AI procurement. The company is positioned as a frontrunner in how large organizations buy AI, which may signal a shift in enterprise purchasing practices.

   It is unclear whether other enterprises will follow Bristol Myers Squibb's approach, and Procurement Magazine does not specify what that approach entails.